| Style | Citing Format |
|---|---|
| MLA | Moghadasi AN, Anjidani N. "Evaluation of the Incidence, Severity, and Mortality Rate of Covid-19 in Patients With Multiple Sclerosis Receiving Interferon Β-1A." Frontiers in Emergency Medicine, vol. 5, no. 2, 2021, pp. -. |
| APA | Moghadasi AN, Anjidani N (2021). Evaluation of the Incidence, Severity, and Mortality Rate of Covid-19 in Patients With Multiple Sclerosis Receiving Interferon Β-1A. Frontiers in Emergency Medicine, 5(2), -. |
| Chicago | Moghadasi AN, Anjidani N. "Evaluation of the Incidence, Severity, and Mortality Rate of Covid-19 in Patients With Multiple Sclerosis Receiving Interferon Β-1A." Frontiers in Emergency Medicine 5, no. 2 (2021): -. |
| Harvard | Moghadasi AN, Anjidani N (2021) 'Evaluation of the Incidence, Severity, and Mortality Rate of Covid-19 in Patients With Multiple Sclerosis Receiving Interferon Β-1A', Frontiers in Emergency Medicine, 5(2), pp. -. |
| Vancouver | Moghadasi AN, Anjidani N. Evaluation of the Incidence, Severity, and Mortality Rate of Covid-19 in Patients With Multiple Sclerosis Receiving Interferon Β-1A. Frontiers in Emergency Medicine. 2021;5(2):-. |
| BibTex | @article{ author = {Moghadasi AN and Anjidani N}, title = {Evaluation of the Incidence, Severity, and Mortality Rate of Covid-19 in Patients With Multiple Sclerosis Receiving Interferon Β-1A}, journal = {Frontiers in Emergency Medicine}, volume = {5}, number = {2}, pages = {-}, year = {2021} } |
| RIS | TY - JOUR AU - Moghadasi AN AU - Anjidani N TI - Evaluation of the Incidence, Severity, and Mortality Rate of Covid-19 in Patients With Multiple Sclerosis Receiving Interferon Β-1A JO - Frontiers in Emergency Medicine VL - 5 IS - 2 SP - EP - PY - 2021 ER - |